Skip to Main Content

Paper Details

The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HRâ¿¿+â¿¿/HER2â¿¿-) advanced/metastatic breast cancer.
Breast Cancer Res Treat
5
2023
Author NameAffiliation
Aditya BardiaMassachusetts General Hospital Cancer Center, Harvard Medical School
Ingrid A MayerVanderbilt-Ingram Cancer Center
Ingrid A Mayer
Eric P WinerDana-Farber Cancer Institute
Eric P WinerYale Cancer Center
Cynthia X MaWashington University School of Medicine
Jill M Spoerke
  • 1 - 7

Datasets

Release 1.2